ELI LILLY & Co — Director's Dealing 2018

Feb 6, 2018

SEC Form 4/A — Form 4/A

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-01-29

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-29	Common Stock	A	1365	$87.60	Acquired	14874	Indirect

Footnotes

F1: This amendment is being filed to correctly report the amount disposed in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5.

F2: Reporting person disclaims beneficial ownership of these shares.